Backman, M.* ; Flenkenthaler, F.* ; Blutke, A. ; Dahlhoff, M.* ; Ländström, E.* ; Renner, S.* ; Philippou-Massier, J.* ; Krebs, S.* ; Rathkolb, B. ; Prehn, C. ; Grzybek, M. ; Coskun, Ü. ; Rothe, M.* ; Adamski, J. ; Hrabě de Angelis, M. ; Wanke, R.* ; Fröhlich, T.* ; Arnold, G.J.* ; Blum, H.* ; Wolf, E.*
Multi-omics insights into functional alterations of the liver in insulin-deficient diabetes mellitus.
Mol. Metab. 26, 30-44 (2019)
Objective: The liver regulates the availability of insulin to other tissues and is the first line insulin response organ physiologically exposed to higher insulin concentrations than the periphery. Basal insulin during fasting inhibits hepatic gluconeogenesis and glycogenolysis, whereas postprandial insulin peaks stimulate glycogen synthesis. The molecular consequences of chronic insulin deficiency for the liver have not been studied systematically.Methods: We analyzed liver samples of a genetically diabetic pig model (MIDY) and of wild-type (WT) littermate controls by RNA sequencing, proteomics, and targeted metabolomics/lipidomics.Results: Cross-omics analyses revealed increased activities in amino acid metabolism, oxidation of fatty acids, ketogenesis, and gluconeogenesis in the MIDY samples. In particular, the concentrations of the ketogenic enzyme 3-hydroxy-3-methylglutaryl-CoA synthase 2 (HMGCS2) and of retinol dehydrogenase 16 (RDH16), which catalyzes the first step in retinoic acid biogenesis, were highly increased. Accordingly, elevated levels of retinoic acid, which stimulates the expression of the gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PCK1), were measured in the MIDY samples. In contrast, pathways related to extracellular matrix and inflammation/pathogen defense response were less active than in the WT samples.Conclusions: The first multi-omics study of a clinically relevant diabetic large animal model revealed molecular signatures and key drivers of functional alterations of the liver in insulin-deficient diabetes mellitus. The multi-omics data set provides a valuable resource for comparative analyses with other experimental or clinical data sets. (C) 2019 The Authors. Published by Elsevier GmbH.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Liver ; Insulin Deficiency ; Transcriptome ; Proteome ; Metabolome ; Lipidome; Protein; Immune; Metabolism; Carnitine; Expression; Database; Pathway; Phosphorylation; Acylcarnitines; Biosynthesis
Keywords plus
Language
english
Publication Year
2019
Prepublished in Year
HGF-reported in Year
2019
ISSN (print) / ISBN
2212-8778
e-ISSN
2212-8778
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 26,
Issue: ,
Pages: 30-44
Article Number: ,
Supplement: ,
Series
Publisher
Elsevier
Publishing Place
Amsterdam
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30205 - Bioengineering and Digital Health
30505 - New Technologies for Biomedical Discoveries
30201 - Metabolic Health
90000 - German Center for Diabetes Research
Research field(s)
Enabling and Novel Technologies
Genetics and Epidemiology
Helmholtz Diabetes Center
PSP Element(s)
G-500390-001
A-630600-001
G-500692-001
G-505600-003
G-502600-002
G-500600-001
Grants
Copyright
Erfassungsdatum
2019-06-04